APTANOMICS

The information system in a small biotech company.

#SimilarOrganizations #More

APTANOMICS

Industry:
Biotechnology Information Technology

Status:
Active


Similar Organizations

microthermics-logo

MicroThermics

MicroThermics is an information technology and biotechnology company.

polgenix-logo

Polgenix

Polgenix is a small biotech company.

stopford-logo

Stopford

Stopford Information Systems is an information technology company.

More informations about "Aptanomics"

Aptanomics Company Profile 2024: Valuation, Investors

Aptanomics has 24 total employees. What industry is Aptanomics in? Aptanomicsโ€™s primary industry is Biotechnology. Is Aptanomics a private or public company? Aptanomics is a Private company. What is Aptanomicsโ€™s current revenue? The current revenue for Aptanomics is โ€ฆSee details»

Aptanomics - Crunchbase Company Profile & Funding

Alternatives and possible competitors to Aptanomics may include MicroThermics, Stopford, and Polgenix. Unlock even more features with Crunchbase Pro Start Your Free TrialSee details»

Aptanomics SA - Drug pipelines, Patents, Clinical trials - Synapse

Explore Aptanomics SA with its drug pipeline, therapeutic area, technology platform, .See details»

Aptanomics: Drug pipelines, Patents, Clinical trials - Synapse

Jun 29, 2023 Explore Aptanomics with its drug pipeline, therapeutic area, technology platform, 1 literature. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for Free. Last โ€ฆSee details»

Aptanomics SA Company Profile, Financial and Strategic SWOT

Aptanomics SA operates as a drug discovery company. It develops small-molecule drugs based on its proprietary peptide aptamer technology. The company is developing Bcl antagonist and โ€ฆSee details»

Aptanomics Information - RocketReach

The Aptanomics annual revenue was $4.2 million in 2023. What is the NAICS code for Aptanomics? The NAICS codes for Aptanomics are [3254, 32, 32541, 325]. What is the SIC โ€ฆSee details»

Aptanomics - Products, Competitors, Financials, Employees, โ€ฆ

Use the CB Insights Platform to explore Aptanomics's full profile. Aptanomics - Products, Competitors, Financials, Employees, Headquarters Locations Technology VendorsSee details»

Aptanomics and Nanosyn collaborate to discover new cancer โ€ฆ

Sep 27, 2005 Aptanomics SA, a specialist in the application of innovative protein technologies for drug discovery, and Nanosyn Inc, a chemistry-based... Close X. Select your language. โ€ฆSee details»

Aptanomics - Crunchbase

The information system in a small biotech company.See details»

Aptanomics Stock Price, Funding, Valuation, Revenue ... - CB Insights

See Aptanomics funding rounds, investors, investments, exits and more. Evaluate their financials based on Aptanomics's post-money valuation and revenue. Aptanomics Stock Price, Funding, โ€ฆSee details»

Aptanomics appoints Michael Courtney as Chairman and Chief

Sep 27, 2005 Lyon, France, June 24, 2003 -- Aptanomics SA, a drug discovery company using proprietary peptide aptamer technology, announced today that...See details»

APTANOMICS Trademark - Registration Number 2739610 - Serial โ€ฆ

Full line of industrial chemical preparations used in producing pharmaceuticals, medicinal preparations, veterinary preparations; chemicals for use in the manufacture of pharmaceutical, โ€ฆSee details»

| BioWorld

Nov 6, 2002 Lyon-based Aptanomics' CEO, John Hawken, a start-up specialist who previously oversaw the creation and early stage development of Neurotech SA, of Evry; Entomed, of โ€ฆSee details»

Collaboration to discover new cancer drugs | Scientist Live

Aptanomics SA, a specialist in the application of protein technologies for drug discovery, and Nanosyn Inc, a chemistry-based company applying its technology for the design, synthesis โ€ฆSee details»

Aptanomics Raises EUR7M For Peptide Aptamer-Based Platform

Aptanomics Raises EUR7M For Peptide Aptamer-Based Platform. Nov. 6, 2002. By James Etheridge. No Comments. BioWorld Asia. Popular Stories. Today's news in brief. BioWorld. โ€ฆSee details»

Research programme: anticancer therapeutics

Aptanomics and Nanosyn have entered into a research collaboration to discover and develop compounds for the treatment of cancer. Aptanomics will apply itsSee details»

Aptanomics and Nanosyn collaborate to discover new cancer โ€ฆ

Sep 27, 2005 Aptanomics SA, a specialist in the application of innovative protein technologies for drug discovery, and Nanosyn Inc, a chemistry-based... Schließen X. Bitte wählen Sie eine โ€ฆSee details»

Research programme: anticancer peptide aptamers - Aptanomics SA

Research programme: anticancer peptide aptamers - Aptanomics SA Alternative Names: AP 1; AP 2; AP 3; Aptamers Latest Information Update: 04 Nov 2017. Price : $50 * Buy Profile. Adis โ€ฆSee details»

Aptanomics, BI Sign Deal In Aptamer Drug Discovery - BioWorld

Aug 3, 2005 Aptanomics, BI Sign Deal In Aptamer Drug Discovery. Aug. 3, 2005. By James Etheridge. No Comments. BioWorld Asia. Popular Stories. Today's news in brief. BioWorld. โ€ฆSee details»

Peptide aptamers as guides for small-molecule drug discovery

1 Aptanomics, 181-203 avenue Jean Jaurès, 69007 Lyon, France. PMID: 16580975 DOI: 10.1016/j.drudis.2006.02.007 Abstract Peptide aptamers are combinatorial protein reagents โ€ฆSee details»

linkstock.net © 2022. All rights reserved